Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Antithrombin-III activator

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Thromboembolism 2 D013923 ClinicalTrials
Ischemic Stroke 2 D000083242 ClinicalTrials
Kidney Neoplasms 1 D007680 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201414
FDA SRS 3S182ET3UA